Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis
NCT06609343
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
16
Enrollment
OTHER
Sponsor class
Conditions
End Stage Renal Disease
Fatigue
Interventions
DRUG:
Bupropion Hydrochloride 150 MG
Sponsor
The University of Texas Health Science Center at San Antonio